• Reaction to the FY15 Omnibus Spending Bill


    The following statement may be attributed to Carrie Wolinetz, PhD, President, United for Medical Research: WASHINGTON – “Congress has missed a major opportunity to fund advances in science and medicine that improve our nation’s health and economic outlook, with nearly flat funding for the National Institutes of Health in its FY15 omnibus bill. With millions […]

  • New Interactive Map Spotlights State-level Impact of NIH Funds


    NIH funding supports 400,000 jobs nationwide while also supporting research to combat our most common fatal diseases WASHINGTON, D.C., (September 9, 2014)— United For Medical Research, a coalition of leading research institutions, patient and health advocates, and private industry, today launched a user-friendly map spotlighting the state-level impact of federal research funds provided by the […]

  • Reaction to the Senate LHHS Subcommittee’s FY15 Markup


    The following is a statement from United for Medical Research (UMR): WASHINGTON – “We applaud Senators Harkin & Moran and the Labor, Health and Human Services, and Education, and Related Agencies appropriations subcommittee for proposing a $605 million increase in funding for the National Institutes of Health (NIH). We appreciate the subcommittee’s effort to mitigate recent […]

  • Senate Appropriations Committee to Hold Hearing on US Innovation Deficit


    From our friends at the Association of American Universities: The Senate Appropriations Committee will hold a hearing tomorrow (Tuesday, April 29) at 2:30 ET on driving innovation through federal research investments.  Chairwoman Mikulski has said that the Committee is convening the hearing over concern about the nation’s innovation deficit.  Here are links to the testimony […]

  • Reaction to President Obama’s FY15 Budget for Biomedical Research


    WASHINGTON – The following is a statement from United for Medical Research (UMR) in reaction to President Obama’s FY15 budget: “President Obama’s FY 2015 budget proposal for biomedical research falls short of reversing the damage done by a decade of flat funding to the National Institutes of Health and recent cuts from sequestration. Our nation […]